Pharmafile Logo
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • - PMLiVE
  • Communiqué 53 Cover Image

WuXi AppTec

Established in December 2000, WuXi AppTec is a leading global pharmaceutical, biopharmaceutical, and medical device outsourcing company with operations in China and the United States. As a research-driven and customer-focused company, WuXi AppTec provides a broad and integrated portfolio of laboratory and manufacturing services from discovery to commercialization.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

Genesis Research Group logo

Genesis Research Group

Genesis Research Group empowers life science companies to innovate differently by fundamentally transforming the way they engage with research partners. Through the integration of robust stakeholder insights (RPR), data-agnostic expertise,…

View Profile

Market access, Regulatory affairs, Research and development

Company Details

WuXi AppTec
2540 Executive Drive, St. Paul, MN 55120, USA
+1 888- 794-0077
Contact WuXi AppTec
Website

 Latest Content from PMHub 

Middlesex House hosts its first Lucid Spirit pub quiz

Press Releases | December 6, 2019 | Lucid Group Communications Limited

Dec 6, 2019Middlesex House hosted its first Lucid Spirit fundraising activity for its charity partner the Wycombe Homeless Connection. The turnout was excellent, and everyone’s synapses were on fire. However,...

Language barriers: Obesity has become a loaded word

White Papers and Resources | December 5, 2019 | Say Communications

We have a worldwide ‘obesity crisis’. Everyone knows this; obesity is in the news almost every week for one reason or another, but what we seem less sure of is...

Spotlight interview: 15 minutes on digital in medical communications

White Papers and Resources | December 5, 2019 | OPEN Health

Gemma Allen, Head of Digital Communications, OPEN Health takes 15 minutes to answer some key questions on digital in medical communications

Generating data on long-term outcomes with gene and other advanced therapies

White Papers and Resources | December 5, 2019 | OPEN Health

Gene therapy and advanced cell-based therapies offer patients hope and the potential to make them ‘chronically well’.

Behavioural Science in Healthcare

White Papers and Resources | December 4, 2019 | Page & Page Health

Personal health and wellbeing has never been more a part of the public conscious than it is now.

Why aren’t doctors using digital therapeutics?

White Papers and Resources | December 4, 2019 | Blue Latitude Health

The digital therapeutics market is set to reach almost $1 billion by 2026 as wearables and apps continue to play an important role in enhancing healthcare. However, adoption of these...

Four Health wins Judges Special Recognition Award PMEA 2019

Press Releases | November 29, 2019 | Four Agency Worldwide

We’re delighted to have won the Judge’s Special Recognition Award at the PMEA Awards 2019! Huge congratulations to the whole team for another amazing win for the GLAD I Took...

Lucid Group announces the appointment of a new Legal and Compliance manager

Press Releases | November 27, 2019 | Lucid Group Communications Limited

Lucid Group demonstrates continual investment in its infrastructure by appointing Sebastian Goodwin as its new Legal and Compliance manager.Sebastian studied politics and trained to be a lawyer before moving into...

Lucid Group Experience the Magic of Mindfulness, Meditation and Massage

Press Releases | November 27, 2019 | Lucid Group Communications Limited

This time of year can be busier than normal. Lucid Group understand the importance of taking some time out to relax and unwind. That's why yesterday, relaxation, meditation and mindfulness...

Are you using Patient-Reported Outcomes (PROs) in your oncology trials? If not, why not?

White Papers and Resources | November 27, 2019 | OPEN Health

A recent blog, published by Sarah Tressel Gary and Rinah Yamamoto called “Patient-Reported Outcome Data in Oncology Trials - Part 2: Clinical Benefit and Patient Preference”, has sparked our interest....